Usefulness of brain natriuretic peptide release as a surrogate marker of the efficacy of long-term cardiac resynchronization therapy in patients with heart failure

American Journal of Cardiology

Volumn 91, Issue 6, 2003, Pages 755-758

  Sinha, Anil Martin ^a   Filzmaier, Karsten ^a   Breithardt, Ole Alexander ^a   Kunz, Dagmar ^a   Graf, Jürgen ^a   Markus, Kai U ^a   Hanrath, Peter ^a   Stellbrink, Christoph ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CREATINE; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; BLOOD GAS ANALYSIS; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ARTICLE; CORRELATION ANALYSIS; CREATINE KINASE BLOOD LEVEL; DISEASE MARKER; ECHOCARDIOGRAPHY; EVALUATION; EXERCISE; FEMALE; HEART FAILURE; HEART LEFT BUNDLE BRANCH BLOCK; HEART VENTRICLE PACING; HUMAN; KIDNEY FUNCTION; LONG TERM CARE; MALE; PRIORITY JOURNAL; PROTEIN SECRETION; UREA NITROGEN BLOOD LEVEL;

EID: 0037443654     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(02)03425-2     Document Type: Article

References (20)

1. Blanc J.J., Etienne Y., Gilard M., Mansourati J., Munier S., Boschat J., Benditt D.G., Lurie K.G. Evaluation of different ventricular pacing sites in patients with severe heart failure. Circulation. 96:1997;3273-3277.
2. Kass D.A., Chen C.H., Curry C., Talbot M., Berger R., Fetics B., Nevo E. Improved left ventricular mechanism from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation. 99:1999;1567-1573.
3. Auricchio A., Stellbrink C., Block M., Sack S., Vogt J., Bakker P., Klein H., Kramer A., Ding J., Salo R., et al. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group. Circulation. 99:1999;2993-3001.
4. Cazeau S., Leclercq C., Lavergne T., Walker S., Varma C., Linde C., Garrigue S., Kappenberger L., Haywood G.A., Santini M., Bailleul C., Daubert J.C. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 344:2001;873-880.
5. Abraham W.T., Fisher W.G., Smith A.L., Delurgio D.B., Leon A.R., Loh E., Kocovic D.Z., Packer M., Clavell A.L., Hayes D.L., et al. Cardiac resynchronization in chronic heart failure. N Engl J Med. 346:2002;1845-1853.
6. Auricchio A., Stellbrink C., Sack S., Block M., Vogt J., Bakker P., Huth C., Schöndube F., Wolfhard P., Böcker D., Kirkels H. Long-term clinical effect of hemodynamical optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol. 39:2002;2026-2033.
7. Filzmaier K., Sinha A.M., Breithardt O.A., Stiegler H., Fischer Y., Graf J., Mischke K., Stellbrink C. Short-term effects of cardiac resynchronization on brain natriuretic peptide release in patients with systolic heart failure and ventricular conduction disturbance. (abstr) J Am Coll Cardiol. 39:2002;104.
8. Yasue H., Yoshimura M., Sumida H., Kikuta K., Kugiyama K., Jougasaki M., Ogawa H., Okumura K., Mukoyama M., Nakao K. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation. 90:1994;195-203.
9. Tsutamoto T., Wada A., Maeda K., Hisanaga T., Maeda Y., Fukai D., Ohnishi M., Sugimoto Y., Kinoshita M. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction . Circulation. 96:1997;509-516.
10. Dao Q., Krishnaswamy P., Kazanagra R., Harrison A., Amirnovin R., Lenert L., Clopton P., Alberto J., Hlavin P., Maisel A. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent care setting. J Am Coll Cardiol. 37:2001;379-385.
11. Groenning B.A., Nilsson J.C., Sondergaard L., Kjaer A., Larsson H.B., Hildebrandt P.R. Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentration. Eur J Heart Fail. 3:2001;699-708.
12. Maisel A.S., Koon J., Krishnaswamy P., Kazenegra R., Clopton P., Gardetto N., Morrisey R., Garcia A., Chiu A., DeMaria A. Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J. 141:2001;367-374.
13. Maeda K., Tsutamota T., Wada A., Mabuchi N., Hayashi M., Tsutsui T., Ohnishi M., Sawaki M., Fujii M., Matsumoto T., Kinoshita M. High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Cardiol. 36:2000;1587-1593.
14. Stanek B., Frey B., Huelsmann M., Berger R., Sturm B., Strametz-Juranek J., Bergler-Klein J., Moser P., Bojic A., Hartter E., Pacher R. Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction. J Am Coll Cardiol. 38:2001;436-442.
15. Troughton R.W., Frampton C.M., Yandle T.G., Espiner E.A., Nicholls M.G., Richards A.M. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet. 355:2000;1126-1130.
16. Fischer Y., Filzmaier K., Stiegler H., Graf J., Fuhs S., Franke A., Janssens U., Gressner A.M. Evaluation of a new, rapid bedside test for quantitative determination of B-type natriuretic peptide. Clinical Chem. 47:2001;591-594.
17. Stellbrink C., Breithardt O.A., Franke A., Sack S., Bakker P., Auricchio A., Pochet T., Salo R., Kramer A., Spinelli J. Impact of cardiac resynchronization therapy using hemodynamically optimized pacing on left ventricular remodeling in patients with congestive heart failure and ventricular conduction disturbances. J Am Coll Cardiol. 38:2001;1957-1965.
18. Nelson G.S., Berger R.D., Fetics B.J., Talbot M., Spinelli J.C., Hare J.M., Kass D.A. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation. 102:2000;3053-3059.
19. Yu C.M., Chau E., Sanderson J.E., Fan K., Tang M.O., Fung W.H., Lin H., Kong S.L., Lam Y.M., Hill M.R.S., Lau C.P. Tissue Doppler echocardiography evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation. 105:2002;438-445.
20. Erlebacher J.A., Barbarash S. Intraventricular conduction delay and functional mitral regurgitation. Am J Cardiol. 88:2001;83-86.